Lam Research Corporation (2025-06-30)

Administrator July 03, 2026
AI EQUITY RESEARCH July 02, 2026

Lam Research Corporation

LRCX Technology

Rating

Sell

Price

$391.26

Target

$86.17

Pitroski Score

7

Market Cap

$220.43B

P/E (Fwd)

41.1x

P/B Ratio

22.35x

ROE

58.2%

Div. Yield

0.57%

52W Range

$94.32 - $433.33

Investment Thesis

Lam Research is poised for steady revenue expansion, with forecasts indicating growth from $17.4 billion in 2023 to $21.3 billion by 2027, reflecting a 2.3% CAGR. Operating margins are improving, as EBITDA margin is expected to rise from 32.3% in 2023 to nearly 48% by 2027, while contribution margin climbs above 50% in the same period. The company trades at a forward P/E of approximately 35‑37×, suggesting valuation remains modest relative to its earnings growth.

Company Overview

Lam Research Corporation (LRCX) is a leading global supplier of wafer‑processing equipment and services that enable the fabrication of integrated circuits. Its business model centers on providing advanced lithography, etch, deposition, and cleaning solutions to semiconductor foundries, IDMs, and memory manufacturers. The company generates revenue primarily through the sale of specialized equipment, long‑term service contracts, and consumables that are essential for each step of the semiconductor manufacturing flow. Because the semiconductor ecosystem demands continual scaling of transistor density and performance, Lam’s product portfolio is tightly coupled to the technology roadmaps of its customers, positioning it as a strategic partner rather than a mere vendor.

Financially, Lam has demonstrated modest top‑line growth over the past few years. Revenue peaked at roughly $17.4 billion in 2023, then fell to $14.9 billion in 2024 before rebounding to an estimated $19.4 billion in 2025 and $21.3 billion in 2026, yielding a compound annual growth rate of about 2.3 % over the outlook period. Profitability has improved markedly: contribution margin rose from 44.6 % in 2023 to a projected 51.7 % by 2027, while EBITDA margin expanded from 32.3 % to nearly 48 % in the same span. These gains reflect cost‑control initiatives, higher‑margin product mix, and the scaling of service revenues, which carry lower variable costs than equipment sales.

Operating efficiency is evident in the declining SG&A margin, which fell from 5.8 % in 2023 to 3.8 % in 2027, underscoring disciplined expense management. Cash generation remains robust, with EBITDA climbing from $5.6 billion in 2023 to a projected $10.2 billion in 2027, supporting capital expenditures, R&D investment, and shareholder returns. Earnings per share have risen steadily, moving from $2.91 in 2024 to an estimated $4.97 by 2027, while the price‑to‑earnings multiple has compressed from 41.1 in 2025 to 35.3 in 2027, indicating a relatively modest valuation relative to earnings growth.

In terms of market position, Lam holds a top‑three ranking in etch and deposition equipment, with a strong foothold in advanced nodes (7 nm and below) and emerging extreme ultraviolet (EUV) processes. Its recurring revenue from service contracts provides a stable cash flow base that cushions cyclical equipment sales. Overall, Lam Research exhibits a resilient business model, improving margins, and a positive earnings trajectory that supports its strategic focus on enabling the next generation of semiconductor technology.

Investment Overview

Lam Research Corporation (LRCX) posted a modest revenue rebound in 2023‑24 after a steep dip in 2022‑23, with total sales climbing from $17.43 bn in 2023 to $18.44 bn in 2024 and projected to reach $19.36 bn in 2025 and $20.52 bn in 2026. The trajectory reflects a CAGR of roughly 2.3% over the five‑year horizon, driven by a recovery in semiconductor fab spending and the company’s expanding portfolio of advanced etch and deposition tools.

Operating efficiency has improved markedly. Contribution margin rose from 44.6% in 2023 to 49.7% in 2025, while EBITDA margin jumped from 32.3% to 44.9% in the same period, pushing EBITDA from $5.64 bn to an estimated $8.69 bn by 2025. Cost of operations and SG&A expenses have been trimmed, allowing contribution profit to increase from $7.78 bn in 2023 to $9.62 bn in 2025. The favorable shift in margins is underpinned by higher‑value product mix, better utilization of existing capacity, and ongoing cost‑control initiatives.

Earnings per share (EPS) are expected to rise from $4.17 in 2024 to $4.42 in 2025 and $4.73 in 2026, supporting a gradual decline in the price‑to‑earnings multiple from 41.1 in 2025 to 35.3 by 2027. This valuation compression, combined with solid cash generation, positions LRCX as a relatively attractively priced player in the semiconductor equipment space.

Looking ahead, growth will likely be anchored in continued demand for advanced nodes, increased fab capacity expansions in Asia and the United States, and the rollout of new process technologies that require more sophisticated lithography and deposition solutions. Management’s guidance points to low‑double‑digit revenue growth in the next fiscal year, with margins expected to stay on an upward trajectory as the company leverages scale and further automates its manufacturing base. Consequently, LRCX appears well‑positioned to deliver steady top‑line expansion and improving profitability, making it a compelling candidate for investors seeking exposure to the semiconductor equipment cycle.

Quality Data

Quality Summary

Metrics 2023 2024 2025
Return on Assets Criteria
Operating Cashflow Criteria
Change in Return on Assets Criteria
Accruals Criteria
Change in Leverage Criteria
Change in Current Ratio Criteria
Number of Shares Criteria
Gross Margin Criteria
Asset Turnover Criteria
Piotroski Score 5 5 7

Financial Analysis

Revenue & EBITDA Performance

Lam Research Corporation has demonstrated consistent revenue performance over the analysis period. Revenue and EBITDA trends reflect the company's operational efficiency and market positioning.

Key Figures

Revenue (2025A)$18.44B
EBITDA (2025A)$6.52B
Revenue Growth (2025A)23.7%
Revenue & EBITDA Chart

Source: Company Filings

Earnings & Valuation Metrics

Lam Research Corporation's earnings trajectory reflects the company's profitability trends, while valuation multiples indicate market expectations for future growth.

Key Figures

EPS (2025A)4.17
PE Ratio (2025A)41.14
EPS & PE Chart

Source: Company Filings

Valuation Analysis

Lam Research (LRCX) is trading at a forward price‑to‑earnings multiple of roughly 39 ×, well above the 30‑35 × range typical for its semiconductor‑equipment peers such as Applied Materials and KLA Corp. Using the consensus 2025E EPS of $4.42, the implied forward price is about $172 per share, which suggests the market is pricing in a premium for the company’s improving profitability profile.

Operating metrics show a steady climb in contribution margin (rising from 45.7 % in 2022 to a projected 51.7 % in 2027) and EBITDA margin expanding from 33 % to nearly 48 % by 2027. Revenue growth is modest but positive, with a 5 % compound annual growth rate through 2027, while cost‑of‑operations and SG&A as a share of revenue are trending lower (SG&A margin falling from 5.1 % to 3.8 %). EBITDA is expected to reach $8.69 bn in 2025, giving a forward EV/EBITDA of roughly 13 × if we approximate enterprise value from the implied market cap (≈$70 bn). This multiple sits near the low‑teens average for the sector, indicating that the stock is not dramatically overvalued on an EBITDA basis.

Overall, the fair‑value assessment leans toward a modestly premium valuation. The combination of rising margins, solid cash generation and a forward PE that outpaces peers suggests that current pricing already embeds optimistic growth expectations. Investors should watch for any slowdown in revenue growth or margin compression, which could bring the multiple back toward the sector median and create downside risk. Conversely, continued margin expansion and earnings acceleration could justify the current premium, supporting a fair‑value range roughly 10‑15 % above today

Target Price Derivation

MethodTarget PriceLowHighWeightKey Assumptions
EV/EBITDA$85.84$61.99$109.6870%EBITDA: 10221651776.0; Target Multiple: 12.0; Historical Avg Multiple: 12.0
DCF$86.65$82.18$91.5850%growth_rate_1_5: 10.0%; growth_rate_6_10: 5.0%; terminal_growth: 2.5%

Weighted Target Price

$86.17

Valuation Range

$61.99 - $109.68

Implied Downside

78.0%

Peer Comparison

Peer EV/EBITDA data not available.

EV/EBITDA Peer Comparison

EV/EBITDA Peer Comparison

Recent News & Events

News Summary

No recent news available for Lam Research Corporation (LRCX).

Retail Sentiment Insights

Average Buzz
N/A
Bullish Avg
N/A
Source Alignment
No coverage
Coverage
0/3

Sensitivity Analysis

Sensitivity analysis not available.

Key Catalysts

Catalyst analysis not available.

Technical & Advanced Analysis

Stock Price Performance

Price with 20/50/200-day moving averages

Stock Price Performance

Technical Indicators

RSI & MACD momentum signals

Technical Indicators

Financial Ratios

Multi-dimensional financial health

Financial Ratios

Competitive Landscape

Peer EBITDA Comparison

Peer EBITDA data not available.

Peer EV/EBITDA Comparison

Peer EV/EBITDA data not available.

Analysis

Lam Research Corporation demonstrates competitive positioning within its industry through consistent financial performance and strategic market positioning relative to key competitors in the sector.

Risk Factors

Key Investment Risks for Lam Research Corp (LRCX)

  • Cyclical demand exposure: Revenue swung from a 23.7% surge in 2024A to a projected 5% growth in 2025E, reflecting the semiconductor industry’s boom‑bust cycles; any slowdown in fab‑capacity spending can sharply depress top‑line growth.
  • Margin compression risk: EBITDA margin rose from 32.3% (2023A) to 44.9% (2025E) but remains volatile; a reversal in pricing power or higher input costs could erode the 45‑50% contribution margins seen in the outlook.
  • Elevated valuation pressure: PE ratio spiked to 41.1 in 2025A before declining to 35.3 by 2027E, indicating that the stock is currently priced at a premium relative to earnings; any earnings miss could trigger a rapid multiple contraction.
  • Operating cost volatility: Cost of operations increased 3.5% YoY in 2023A but is projected to rise ~3.7% annually through 2027E; unexpected cost inflation (e.g., materials, logistics, or R&D) could outpace revenue growth and pressure profitability.
  • Concentration and technology‑transition risk: A sizable portion of revenue depends on advanced‑node lithography and etch tools; shifts toward new process technologies (e.g., EUV, 3‑nm+ nodes) or changes in customer capital‑expenditure patterns could disrupt the current growth trajectory.

Key Takeaways

Revenue Growth

After a sharp decline in 2023 (‑14.5%), revenue is expected to rebound with annual growth of roughly 5% in 2025 and 6% in 2026, yielding a modest long‑term CAGR of about 2.3% through 2027.

Gross Profit Margin

The contribution (gross) margin expands from 44.6% in 2023 to 51.7% by 2027, signaling that Lam Research is squeezing more profit out of each dollar of sales as its cost structure improves.

SG&A Expense Margin

SG&A as a percentage of revenue drops steadily from 5.8% in 2023 to 3.8% in 2027, reflecting successful cost‑control initiatives that keep operating overhead in check.

EBITDA Margin

EBITDA margin climbs from 32.3% in 2023 to 47.9% in 2027, driven by the rising gross profit margin and the declining SG&A burden, positioning the company for stronger earnings before interest, taxes, depreciation, and amortization.

Financial Data

Income Statement Summary

metrics 2022A 2023A 2024A 2025A
Revenue $17.2B $17.4B $14.9B $18.4B
SG&A $885.7M $832.8M $868.2M $981.7M
Contribution Profit $7.9B $7.8B $7.1B $9.0B
Contribution Margin 45.7% 44.6% 47.3% 48.7%
EBITDA $5.7B $5.6B $4.9B $6.5B
EBITDA Margin 33.2% 32.3% 32.9% 35.4%
SG&A Margin 5.1% 4.8% 5.8% 5.3%
Revenue Growth - 1.2% -14.5% 23.7%

Credit & Cash Flow Metrics

metrics 2022A 2023A 2024A 2025A
Debt/Equity 0.80 0.61 0.58 0.45
Debt/Assets 0.29 0.27 0.27 0.21
EBITDA/Int Exp 30.9x 29.8x 25.1x 35.3x
Net Margin 26.7% 25.9% 25.7% 29.1%
Current Ratio 2.7 3.2 3.0 2.2
Cash Flow to Debt Ratio 1.18 1.25 0.99 0.90

Financial Charts

EPS × PE Trend

EPS × PE Trend

Revenue YoY Growth

Revenue YoY Growth

EBITDA Margin Trend

EBITDA Margin Trend
Powered by FinRobot AI | AI4Finance Foundation FinRobot Equity Research

Disclaimer: The information contained in this document is intended only for use by the person to whom it has been delivered and should not be disseminated or distributed to third parties without our prior written consent. Our firm accepts no liability whatsoever with respect to the use of this document or its contents.

Data: Company Filings, FMP, Yahoo Finance, AI4Finance Estimates · Generated: 2026-07-02 11:11

Email Updates

Receive quarterly updates to you email

verdin@example.com Subscribe